Other Stories

Five S. Korean firms start clinical trials for developing COVID-19 vaccines Updated: 2021-04-12 17:10:32 KST

And so far there are five South Korean firms that have started clinical trials for their own vaccines.
That's also out of today's special briefing.
Those companies are SK Bioscience, Eubiologics, Cellid, Genexine and GeneOne Life Science.
The health ministry said in Monday's emergency COVID-19 meeting led by President Moon, that the companies aim to begin phase three trials in the second half of this year.
The government will be investing some 61 million dollars of this year's budget to support the trials and will consider additional help if needed.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.